These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9201256)

  • 1. Immunosuppressive retroviral peptides: immunopathological implications for immunosuppressive influences of retroviral infections.
    Haraguchi S; Good RA; Cianciolo GJ; Engelman RW; Day NK
    J Leukoc Biol; 1997 Jun; 61(6):654-66. PubMed ID: 9201256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections.
    Haraguchi S; Good RA; James-Yarish M; Cianciolo GJ; Day NK
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5568-71. PubMed ID: 7777549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products.
    Nelson M; Nelson DS; Cianciolo GJ; Snyderman R
    Cancer Immunol Immunother; 1989; 30(2):113-8. PubMed ID: 2598177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro immunomodulation and in vivo immunotherapy of retrovirus-induced immunosuppression.
    Good RA; Haraguchi S; Lorenz E; Day NK
    Int J Immunopharmacol; 1991; 13 Suppl 1():1-7. PubMed ID: 1668553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retroviral-derived immunosuppressive peptide activates mitogen-activated protein kinases.
    Takahashi A; Day NK; Luangwedchakarn V; Good RA; Haraguchi S
    J Immunol; 2001 Jun; 166(11):6771-5. PubMed ID: 11359835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New monoclonal antibodies against the putative immunosuppressive site of retroviral p15E.
    Lang MS; Oostendorp RA; Simons PJ; Boersma W; Knegt P; van Ewijk W
    Cancer Res; 1994 Apr; 54(7):1831-6. PubMed ID: 7511054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.
    Cianciolo GJ; Copeland TD; Oroszlan S; Snyderman R
    Science; 1985 Oct; 230(4724):453-5. PubMed ID: 2996136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression by retroviruses: implications for xenotransplantation.
    Denner J
    Ann N Y Acad Sci; 1998 Dec; 862():75-86. PubMed ID: 9928208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1.
    Kleinerman ES; Lachman LB; Knowles RD; Snyderman R; Cianciolo GJ
    J Immunol; 1987 Oct; 139(7):2329-37. PubMed ID: 2821111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation by peptide analogs of retroviral envelope protein.
    Mehrotra S; Mishra KP; Yadav VS; Bhattacharya M; Pandey D; Haq W; Singh VK
    Peptides; 2003 Jul; 24(7):979-85. PubMed ID: 14499276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.
    Harris DT; Cianciolo GJ; Snyderman R; Argov S; Koren HS
    J Immunol; 1987 Feb; 138(3):889-94. PubMed ID: 2433333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive actions of retroviruses.
    Good RA; Ogasawara M; Liu WT; Lorenz E; Day NK
    Lymphology; 1990 Jun; 23(2):56-9. PubMed ID: 2170777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic peptide homologous to retroviral envelope protein down-regulates TNF-alpha and IFN-gamma mRNA expression.
    Haraguchi S; Good RA; Cianciolo GJ; Day NK
    J Leukoc Biol; 1992 Oct; 52(4):469-72. PubMed ID: 1402393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent immunosuppressive retroviral peptide: cytokine patterns and signaling pathways.
    Haraguchi S; Good RA; Day-Good NK
    Immunol Res; 2008; 41(1):46-55. PubMed ID: 18506644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the immunosuppressive activity of CKS-17, a synthetic retroviral envelope peptide, by muramyl dipeptide.
    Gauduin MC; Vogel FR; Simon JP; Audibert FA; Chedid LA
    Viral Immunol; 1993; 6(3):175-83. PubMed ID: 8292225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The suppressive effect of a synthetic retroviral peptide on the human IFN gamma production is abrogated by the combined stimulation with IL-1 and IL-2.
    Ogasawara M; Cianciolo GJ; Mitani M; Kizaki T; Good RA; Day NK
    Cancer Detect Prev; 1991; 15(3):205-9. PubMed ID: 1905580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses.
    Mitani M; Cianciolo GJ; Snyderman R; Yasuda M; Good RA; Day NK
    Proc Natl Acad Sci U S A; 1987 Jan; 84(1):237-40. PubMed ID: 3025858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional down-regulation of tumor necrosis factor-alpha gene expression by a synthetic peptide homologous to retroviral envelope protein.
    Haraguchi S; Good RA; Cianciolo GJ; James-Yarish M; Day NK
    J Immunol; 1993 Sep; 151(5):2733-41. PubMed ID: 8360488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E.
    Langhammer S; Hübner J; Kurth R; Denner J
    Immunology; 2006 Feb; 117(2):229-37. PubMed ID: 16423059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide.
    Nelson M; Nelson D
    Cancer Immunol Immunother; 1990; 30(6):331-41. PubMed ID: 2302724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.